Wird geladen...
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
BACKGROUND: We previously reported prolonged progression-free survival and marginally prolonged overall survival among postmenopausal patients with hormone receptor–positive metastatic breast cancer who had been randomly assigned to receive the aromatase inhibitor anastrozole plus the selective estr...
Gespeichert in:
| Veröffentlicht in: | N Engl J Med |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885383/ https://ncbi.nlm.nih.gov/pubmed/30917258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1811714 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|